A detailed history of Zega Financial, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Zega Financial, LLC holds 1,748 shares of LLY stock, worth $1.39 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
1,748
Previous 2,321 24.69%
Holding current value
$1.39 Million
Previous $2.1 Billion 26.3%
% of portfolio
0.23%
Previous 0.37%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $442,436 - $550,091
-573 Reduced 24.69%
1,748 $1.55 Billion
Q2 2024

Aug 12, 2024

BUY
$724.87 - $909.04 $1.68 Million - $2.11 Million
2,321 New
2,321 $2.1 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $755B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Zega Financial, LLC Portfolio

Follow Zega Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zega Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zega Financial, LLC with notifications on news.